Clinical Trial Update: Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery [Phase 2]

View source ↗

Summary

Phase 2 study assessing safety and feasibility of Algisyl-LVR for left ventricular restoration in dilated cardiomyopathy patients undergoing open-heart surgery …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy

Drugs mentioned

• Algisyl-LVR

Snippet

Sponsor: LoneStar Heart, Inc. | Conditions: Dilated Cardiomyopathy | Phase 2 | Status: COMPLETED